Screening for Congenital Adrenal Hyperplasia: Adjustment of 17-Hydroxyprogesterone Cut-Off Values to Both Age and Birth Weight Markedly Improves the Predictive Value
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Newborn screening procedures for congenital adrenal hyperplasia (CAH) are still suboptimal because of low specificity, particularly in premature infants. This study evaluated a multitiered strategy for reporting abnormal 17-hydroxyprogesterone screening values that simultaneously takes into account not only birth weight but also age at sampling. A cautious three-tiered cut-off scheme was used during the initial 24 months of CAH screening in Bavaria. Data were then reanalyzed using five birth weight classes to reflect more precisely the markedly higher values in low-birth-weight newborns. Because 17-hydroxyprogesterone values apparently decline with increasing age, these classes were then further subdivided into a total of 21 groups according to the age at sampling. Based on this reanalysis, we defined new multitiered cut-off levels and used them for the next 18 months. A total of 538466 newborns were screened from January 1999 to June 2002; 51 CAH cases were detected. Application of the new threshold values resulted in a 35% reduction of the total recall rate (from 1.13% to 0.74%) and an increase in the positive predictive value from 0.84% to 1.29% without reducing diagnostic sensitivity. This improvement of CAH screening can be achieved by simply using request forms that ask for both age and birth weight at the time of sampling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Radioimmunoassay (RIA) was the first method developed (250), but automated time-resolved dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA) has almost completely supplanted other immunoassays (251).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [251]
In the citing paper
“There are no universally accepted standards for stratifying infants, but most laboratories use a series of birth weight-adjusted cut-offs (65-67).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [66]
Citations
Cites
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Krone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397
Self-citationPang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392
Wedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
Therrell, B. L., Berenbaum, S. A., Manter-Kapanke, V., Simmank, J., Korman, K., Prentice, L., Gonzalez, J., & Gunn, S. (1998) · Pediatrics · doi:10.1542/peds.101.4.583 · Cited by 344
Molecular and clinical advances in congenital adrenal hyperplasia
Miller, W. L., & Levine, L. S. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80334-7 · Cited by 178
(1991) · Europe PMC (PubMed Central) · Cited by 164
Wong, T., Shackleton, C. H., Covey, T. R., & Ellis, G. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1830 · Cited by 159
Allen, D. B., Hoffman, G. L., Fitzpatrick, P., Laessig, R., Maby, S., & Slyper, A. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70321-4 · Cited by 153
Caulfield, M. P., Lynn, T., Gottschalk, M. E., Jones, K. L., Taylor, N. F., Malunowicz, E. M., Shackleton, C. H. L., Reitz, R. E., & Fisher, D. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8712 · Cited by 120
Cited by
Items 101–127 of 127
Cutoff levels for newborn screening of 21-OH deficiency in a Brazilian metropolitan area
Gameleira, K. P. D., Thomas, J. D. V., de Araújo, V. G. B., Bolognani, C. V., Fernandes, S. E. S., & Amorim, F. F. (2025) · Jornal de Pediatria · doi:10.1016/j.jped.2025.03.003 · Cited by 1
Transition of pediatric endocrine patients to adult care
Kamboj, M. K., Greydanus, D. E., Bricker, L. A., & Patel, D. R. (2010) · International Journal on Disability and Human Development · doi:10.1515/ijdhd.2010.025 · Cited by 1
Nigam, A., Elahi, A. A., Varun, N., & Gupta, N. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-226122 · Cited by 1
Aspectos relevantes del tamiz neonatal para hiperplasia suprarrenal congénita
Trejo, M. A. H., Arguinzoniz-Valenzuela, S. L., Pérez, L. D. A. H., Parra, G. C., Ibarra‐González, I., Amieva, M. V., Córdova, L. E. B., Baqué, I. G., & Flores, E. P. G. (2018) · Acta Pediátrica de México · doi:10.18233/apm39no6pp14s-24-s1718 · Cited by 5
Case 1: Electrolyte Abnormalities in 7-day-old Girl
Kaminecki, I., Vates, T. S., Barrows, F., & Hudome, S. M. (2019) · Pediatrics in Review · doi:10.1542/pir.2017-0195 · Cited by 1
Abnormal Newborn Screen During a Pandemic
Mak, D., Akinseye, L. I., Lahoti, A., & Diaz-Thomas, A. (2022) · NeoReviews · doi:10.1542/neo.23-3-e212 · Cited by 1
A three-year follow-up of congenital adrenal hyperplasia newborn screening
Pezzuti, I. L., Barra, C. B., Mantovani, R. M., Januário, J. N., & Silva, I. N. (2014) · Jornal de Pediatria (Versão em Português) · doi:10.1016/j.jpedp.2013.08.006 · Cited by 3
Silveira, E. L. (2008) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 2
Bioanalytical Method Development: Considering Information From A Suite of Complementary Methods
Fountain, M. E. (2012) · Bioanalysis · doi:10.4155/bio.11.307 · Cited by 1
Neugeborenenscreening auf Endokrinopathien
Zabransky, S. (2009) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-009-2043-5 · Cited by 2
Hiperplasia suprarrenal congénita: formas precoces
Samara‐Boustani, D., Bachelot, A., Pinto, G., Thibaud, E., Touraine, P. A., & Polak, M. (2010) · EMC - Pediatría · doi:10.1016/s1245-1789(10)70185-2
Congenital Adrenal Hyperplasia: Diagnosis, Management, and Long Term Outcomes
Ammini, A. C. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch6
Hayashi, G. Y. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2016.tde-06062016-120400
Development of the Reproductive Tract
(2005) · CRC Press eBooks · doi:10.1201/b14349-2
Screening for Neonatal Genetic Disorders
WILLIAMS, M. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-0300-7.50047-8
Application of Pharmacometrics to Rare Diseases
AHMED, M. A. (2016) · University of Minnesota Digital Conservancy (University of Minnesota)
Problems of neonatal screening on congenital adrenal hyperplasia
Zelinska, N., Погадаєва, Н. Л., Вікторівна, Г. Є., Ніфонтова, Л. В., & Орлова, Т. О. (2013) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.2(43).2013.77677
de Miranda, M. C. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-29102020-162042
Martínez, F. C., Reyes, E. C. G., Reyes, T. M. E., Suárez, A. F., Martínez, E. M. C., Yera, A. L. A., & Morás, P. L. P. (2021) · Ciencia y Salud · doi:10.22206/cysa.2021.v5i1.pp11-18
de Aragão, C., Alves, D., Júnior, V. B., & Toralles, M. B. P. (2006)
Discharge Planning for the High-Risk Newborn Requiring Intensive Care
Long, C. M., Scharbach, K., & Campbell, D. E. (2016) · doi:10.9954/gb113
Discharge Planning for the High-Risk Newborn Requiring Intensive Care
Long, C. M., Scharbach, K., & Campbell, D. E. (2020) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610022255-39
Newborn screening for congenital adrenal hyperplasia: beyond 17‐hydroxyprogesterone concentrations
Witchel, S. F. (2019) · Jornal de Pediatria (Versão em Português) · doi:10.1016/j.jpedp.2018.08.001 · Cited by 2
Lipidomics in Clinical Diagnostics
Selvalatchmanan, J., Wenk, M. R., & Bendt, A. K. (2023) · Wiley eBooks · doi:10.1002/9783527836512.ch20
Ormoni steroidei surrenalici: 17-idrossiprogesterone
D’Alessandro, A., del GdS-EMM, A. N., & Porzio, O. (2024) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.23736/s1825-859x.24.00255-x · Cited by 1
Gallea, M. N. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
de Hora, M. R., Heather, N. L., Webster, D., Albert, B. B., & Hofman, P. L. (2026) · International Journal of Neonatal Screening · doi:10.3390/ijns12020027
“Using 17OHP can result in many false positive tests, caused by elevated 17OHP measurements due to illness or prematurity [6].”
Metadata
- Authors
- Olgemöller, B., Roscher, A. A., Liebl, B., & Fingerhut, R.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Fingerhut, Ralph
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-12
- Volume
- 88
- Issue
- 12
- Pages
- 5790-5794
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2034018965
- Cited by
- 124
- References
- 25
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 2 · 2016: 7 · 2015: 7 · 2014: 5 · 2013: 5 · 2012: 9
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, newborn screening, 17-hydroxyprogesterone, cut-off values, birth weight, positive predictive value, recall rate, preterm infants
- MeSH terms
- Adrenal Hyperplasia, Congenital, Aging, Birth Weight, False Negative Reactions, Germany, Humans, Infant, Infant, Newborn, Predictive Value of Tests, Sensitivity and Specificity, Incidence, Neonatal Screening, 17-alpha-Hydroxyprogesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.